Retour

Evotec SE

Qualité des données : 100%

EVO

NASDAQ Healthcare Drug Manufacturers - Specialty & Generic

2,52 €

▲ 0,18 € (7,69%)

Cap. Boursière : 895,66M

Également cotée sous EVOTF OTC

Fourchette du Jour

2,48 € 2,57 €

Fourchette 52 Semaines

2,31 € 4,80 €

Volume

134 583

Moyenne 50J / 200J

3,33 € / 3,58 €

Clôture Précédente

2,34 €

Quick Summary

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Healthcare (631 pairs)

Métrique	Action	Médiane du Secteur
P/E	-4,6	0,2
P/B	0,9	3,0
ROE %	-18,9	3,5
Net Margin %	-24,6	3,8
Rev Growth 5Y %	12,3	9,7
D/E	0,5	0,2

Objectif de Cours des Analystes

Hold

7,00 € +177.8%

BPA Prévisionnel

-0,16 €

CA Est.

790,77M

Estimations de Bénéfices

Période	BPA Est.	CA Est.	Analystes
FY2029	0,23 € 0,22 € – 0,26 €	960,64M	1
FY2028	0,14 € 0,13 € – 0,16 €	895,35M	1
FY2027	0,02 € 0,02 € – 0,02 €	864,79M	1

Dividend History

Yield

0,00%

Payout Ratio

0,00%

Growth (3Y)

N/A

Growth (5Y)

N/A

Ex-Date	Payment Date	Amount	Yield
Jan 11, 2019	—	0,29 €	4,93%
Dec 12, 2018	—	0,18 €	5,26%
Nov 08, 2018	—	0,18 €	5,08%
Oct 10, 2018	—	0,18 €	6,09%
Sep 13, 2018	—	0,18 €	4,25%
Aug 10, 2018	—	0,18 €	5,09%
Jul 11, 2018	—	0,18 €	5,89%
Jun 08, 2018	—	0,18 €	5,83%
May 10, 2018	—	0,18 €	7,35%
Apr 11, 2018	—	0,18 €	6,10%
Mar 09, 2018	—	0,18 €	5,74%
Feb 09, 2018	—	0,18 €	6,84%
Jan 11, 2018	—	0,18 €	6,78%
Dec 08, 2017	—	0,18 €	7,52%
Nov 10, 2017	—	0,18 €	6,36%
Oct 11, 2017	—	0,18 €	4,47%
Sep 08, 2017	—	0,18 €	4,93%
Aug 09, 2017	—	0,18 €	7,08%
Jul 11, 2017	—	0,18 €	6,21%
Jun 08, 2017	—	0,20 €	6,93%

Points Clés

Revenue grew 12,31% annually over 5 years — strong growth

Debt/Equity of 0,47 — conservative balance sheet

Negative free cash flow of -114,02M

Revenue growth is decelerating — 1Y growth trails 5Y average by 10,32%

Croissance

Revenue Growth (5Y)

12,31%

Revenue (1Y)1,99%

Earnings (1Y)N/A

FCF Growth (3Y)N/A

Qualité

Return on Equity

-18,92%

ROIC-7,66%

Net Margin-24,60%

Op. Margin-17,88%

Sécurité

Debt / Equity

0,47

Current Ratio1,98

Interest Coverage-12,18

Valorisation

P/E Ratio

-4,57

Forward P/EN/A

P/B Ratio0,94

EV/EBITDAN/A

Dividend Yield0,00%

All Fundamental Metrics

Growth
Revenue Growth (1Y)	1,99%	Revenue Growth (3Y)	2,98%
Earnings Growth (1Y)	N/A	Earnings Growth (3Y)	N/A
Revenue Growth (5Y)	12,31%	Earnings Growth (5Y)	N/A
Profitability
Revenue (TTM)	796,97M	Net Income (TTM)	-196,08M
ROE	-18,92%	ROA	-10,25%
Gross Margin	14,41%	Operating Margin	-17,88%
Net Margin	-24,60%	Free Cash Flow (TTM)	-114,02M
ROIC	-7,66%	FCF Growth (3Y)	N/A
Safety
Debt / Equity	0,47	Current Ratio	1,98
Interest Coverage	-12,18
Dividends
Dividend Yield	0,00%	Payout Ratio	0,00%
Dividend Growth (3Y)	N/A	Dividend Growth (5Y)	N/A
Consecutive Div Years	N/A
Valuation
P/E Ratio	-4,57	Forward P/E	N/A
P/B Ratio	0,94	P/S Ratio	1,12
PEG Ratio	-0,05	Forward PEG	N/A
EV/EBITDA	N/A	Fwd EV/EBITDA	11,97
Forward P/S	1,13	Fwd Earnings Yield	N/A
FCF Yield	-12,73%
Market Cap	895,66M	Enterprise Value	1,03B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	796,97M	781,43M	751,45M	618,03M	500,92M
Net Income	-196,08M	-83,91M	-175,66M	215,51M	6,28M
EPS (Diluted)	-0,56	-0,23	-0,49	0,65	0,02
Gross Profit	114,88M	175,05M	174,07M	151,54M	125,74M
Operating Income	-142,52M	-47,51M	20,85M	41,00M	48,56M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Total Assets	1,91B	2,25B	2,26B	2,24B	1,84B
Total Liabilities	959,98M	1,13B	1,07B	857,48M	951,26M
Shareholders' Equity	952,53M	1,12B	1,19B	1,38B	886,41M
Total Debt	443,54M	815,35M	506,67M	512,92M	601,94M
Cash & Equivalents	306,39M	510,91M	400,70M	699,33M	517,05M
Current Assets	681,96M	903,16M	1,07B	1,10B	806,13M
Current Liabilities	344,59M	464,57M	337,71M	324,52M	255,06M